SorLA in Interleukin-6 Signaling and Turnover

被引:16
|
作者
Larsen, Jakob Vejby [1 ]
Petersen, Claus Munck [1 ]
机构
[1] Aarhus Univ, Dept Biomed, MIND Ctr, Aarhus, Denmark
关键词
IL-6; IL-6R; STAT3; signaling; SorLA; Vps10p domain receptors; cytokines; endocytosis; AMYLOID PRECURSOR PROTEIN; RECEPTOR FAMILY-MEMBER; CILIARY NEUROTROPHIC FACTOR; LIGAND-INDUCED ENDOCYTOSIS; CIRCULATING SOLUBLE LR11; IL-6; RECEPTOR; CYTOPLASMIC DOMAIN; PROPEPTIDE CLEAVAGE; MONOCLONAL-ANTIBODY; DOWN-REGULATION;
D O I
10.1128/MCB.00641-16
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-6 (IL-6) is a multifunctional cytokine with important functions in various physiologic processes. Mice lacking IL-6 exhibit multiple phenotypic abnormalities, such as an inadequate immune and acute-phase response, and elevated levels of circulating IL-6 have been found to accompany several pathological conditions. IL-6 binds the nonsignaling IL-6 receptor (IL-6R), which is expressed as a transmembrane, as well as a secreted circulating protein, before it engages homodimeric gp130 for signaling. Complex formation between IL-6 and the membrane-bound IL-6 receptor gives rise to classic cis signaling, whereas complex formation between IL-6 and the soluble IL-6R results in trans signaling. Here, we report that the endocytic receptor SorLA targets IL-6 and IL-6R. We present evidence that SorLA mediates efficient cellular uptake of both IL-6 and the circulating IL-6R in astrocytes. We further show that SorLA interacts with the membrane-bound IL-6R at the cell surface and thereby downregulates IL-6 cis signaling. Finally, we find that the SorLA ectodomain, released from the cell membrane upon enzymatic cleavage of full-length SorLA, may act as an IL-6 carrier protein that stabilizes IL-6 and its capacity for trans signaling.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Interleukin-6 signaling in osteoblasts promotes osteoclast differentiation
    Palmisano, Biagio
    Chowdhury, Subrata
    Karsenty, Gerard
    Hidalgo, Juan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 91 - 91
  • [22] Interleukin-6 signaling pathway genes in CHD patients
    El Mokhtari, N. E.
    Jagiello, P.
    Wedemeyer, N.
    Schreiber, S.
    Simon, R.
    Ott, S. J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 457 - 457
  • [23] The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover
    Wong, PKK
    Campbell, IK
    Egan, PJ
    Ernst, M
    Wicks, IP
    ARTHRITIS AND RHEUMATISM, 2003, 48 (05): : 1177 - 1189
  • [24] The pro-inflammatory activities of interleukin-6 are mediated by the soluble interleukin-6 receptor via trans-signaling
    Rose-John, Stefan
    CYTOKINE, 2013, 63 (03) : 294 - 294
  • [26] The role of interleukin-6 and interleukin-6/interleukin-6 receptor-α complex in the pathogenesis of multiple myeloma
    Barillé, S
    Bataille, R
    Amiot, M
    EUROPEAN CYTOKINE NETWORK, 2000, 11 (04) : 546 - 551
  • [27] Interleukin-6
    Song, MC
    Kellum, JA
    CRITICAL CARE MEDICINE, 2005, 33 (12) : S463 - S465
  • [28] INTERLEUKIN-6
    LOTZ, M
    CANCER INVESTIGATION, 1993, 11 (06) : 732 - 742
  • [29] ZINC DEFICIENCY ADVERSELY INFLUENCES INTERLEUKIN-4 AND INTERLEUKIN-6 SIGNALING
    Gruber, K.
    Maywald, M.
    Rosenkranz, E.
    Haase, H.
    Pluemaekers, B.
    Rink, L.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2013, 27 (03): : 661 - 671
  • [30] A Role for Soluble Interleukin-6 Receptor As an Antagonist of Interleukin-27 Signaling
    Hashizume, Misato
    Esaki, Keiko
    Matsumoto, Yoshihiro
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S391 - S391